Skip to Main Content
TABLE 4.

Respondents’ Self-Reported Use of Diabetes Therapies

Diabetes TherapiesRespondents With Type 1 Diabetes (%)Respondents With Type 2 Diabetes (%)
Insulin 100 48 
Noninsulin injections (e.g., Bydureon [exenatide extended release], Byetta [exenatide], Victoza [liraglutide], or Symlin [pramlintide]) 13 
Pills 73 
Diet and exercise <1 
Diabetes TherapiesRespondents With Type 1 Diabetes (%)Respondents With Type 2 Diabetes (%)
Insulin 100 48 
Noninsulin injections (e.g., Bydureon [exenatide extended release], Byetta [exenatide], Victoza [liraglutide], or Symlin [pramlintide]) 13 
Pills 73 
Diet and exercise <1 
Close Modal

or Create an Account

Close Modal
Close Modal